Given the indication of a direct role of GEF-H1 in anti-tumor immune responses, we used The Cancer Genome Atlas (TCGA) to investigate the prognostic relevance in cancer patients of the proinflammatory GEF-H1-dependent immune signature obtained from Figure 3 (and outlined in Table S5). This evidence concerns the gene ARHGEF2 and neoplasm.